While most cancers can fuel themselves on glucose, fatty acids, ketones and amino acids, their preferred energy source is glucose (due to the Warburg effect). Calculate your IOE AntiCancer Glucose Score.
Use this app to learn how changes in various lifestyle factors, functional medicine lab results, and your use of off-label drugs and supplements theoretically impact your cancer outcomes.
The basis of IOE AntiCancer Glucose Score is built on a synthesis of evidence-based preclinical, epidemiological and clinical published data.
If you have not had these lab tests done recently, leave the defaulted selected values (normal values) and complete the remainder of the assessment.
Proceed to the IOE AntiCancer Composite Score (only available to IOE Program enrollees). This combines the above IOE AntiCancer Glucose Score with lifestyle factors and functional medicine test results that are known to be associated with cancer outcomes.
Next, calculate your IOE AntiCancer Glutamine & Fatty Acid Score (only available to IOE Program enrollees). This score examines the impact of combining various off-label drugs and supplements that may exert anticancer properties on the metabolism of glutamine and fatty acids. You can skip this assessment if you are not interested in using these compounds.
Finally, calculate your IOE AntiCancer Signaling Pathways Score (only available to IOE Program enrollees). Many off-label drugs and supplements have reported anticancer properties by altering the pathways that promote cancer. You can also skip this assessment if you are not interested in using these compounds.
Targeting Cancer Metabolism and Signaling With Off-Label Drugs and Supplements
Targeting cancer cell metabolism, growth signaling pathways and enhancing anti-cancer immunity are among the hottest topics being explored in oncology, today. It has become increasingly clear that many natural compounds, supplements and FDA-approved medications possess these anticancer properties and look quite promising in both preclinical and clinical studies. In fact, over 200 non-cancer drugs have shown some evidence of anticancer effects. Of these, 50% are supported by relevant human data and 16% are supported by data from at least one positive clinical trial. Some of these drugs include: mebendazole, cimetidine, nitroglycerin, diclofenac, itraconazole, clarithromycin, metformin, aspirin and hydroxychloroquine – all common, generic drugs with excellent safety records and a wide range of data sources showing potent anticancer effects.
If you are confused about the use of off-label drugs and supplements, you are not alone. Dr. Lawenda offers educational consulting services to patients internationally (phone and video options).
Dr. Lawenda often recommends functional medicine lab testing for patients to get a better understanding of their underlying health and variables associated with cancer growth and recurrence.